Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: Testing the evidence for an endophenotypic marker
- 1 August 2012
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 199 (1) , 8-11
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Validation of edible taste strips for identifying PROP taste recognition thresholdsThe Laryngoscope, 2011
- A Test for Measuring Gustatory FunctionThe Laryngoscope, 2008
- Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: Relationship to clinical symptomatology and psychophysical olfactory performanceSchizophrenia Research, 2007
- Phenylthiocarbamide Perception in Patients With Schizophrenia and First-Degree Family MembersAmerican Journal of Psychiatry, 2005
- Diagnostic stability in a Dutch psychosis incidence cohortThe British Journal of Psychiatry, 2004
- Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical featuresSchizophrenia Research, 2004
- Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) groupSchizophrenia Research, 2003
- The Prodromal Phase of First-episode Psychosis: Past and Current ConceptualizationsSchizophrenia Bulletin, 1996
- The association between phenylthiocarbamide (PTC) tasting ability and psychometric variablesBehavior Genetics, 1983
- P.T.C. Sensitivity Among Psychiatric PatientsHuman Heredity, 1968